Back to results
US 2019/0231831 A1Published application
Novel bordetella bronchiseptica bacteriophage bor-brp-1, and use thereof for inhibition of proliferation of bordetella bronchiseptica bacteria
AssigneeIntron Biotechnology, Inc.
InventorsSeong Jun Yoon, Soo Youn Jun, Hyoun Rok Paik, Jee Soo Son, Suk Hwang Park, Byung Kuk Kim, Sang Hyeon Kang
Life of this patent
Estimating the term…
Abstract
The present invention relates to a Podoviridae bacteriophage Bor-BRP-1 (accession no. KCTC 12705BP) isolated from nature, which has an ability to specifically kill Bordetella bronchiseptica bacteria and has a genome represented by SEQ ID NO: 1; and a method for preventing and treating infection with Bordetella bronchiseptica bacteria using a composition comprising the same as an active ingredient.
Claims5
A Podoviridae bacteriophage Bor-BRP-1 (Accession number:
- KCTC 12705BP) isolated from nature, which has an ability to specifically kill Bordetella bronchiseptica and which includes a genome expressed by a SEQ. ID. NO:
- 1.
Dependencies are inferred from the claim text.